Pyroptosis‐Mediated Synergistic Photodynamic and Photothermal Immunotherapy Enabled by a Tumor‐Membrane‐Targeted Photosensitive Dimer
Advanced Materials · 2023-06 · 35 (25)
DOI: 10.1002/adma.202300232 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 25.04.2023. Verfasst von Yuqi Tang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Advanced Materials and School of Chemistry and Chemical Engineering, Southeast University, Nanjing, 211189, China. Hauptthemen laut MEDLINE: Neoplasms, Photochemotherapy. Die Arbeit wurde bisher 187-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: Jiangsu Innovation Team Program, NNSFC, Priority Academic Program Development of Jiangsu Higher Education Institutions.
Abstract (Originalsprache)
Overcoming the resistance to apoptosis and immunosuppression of tumor cells is a significant challenge in augmenting the effect of cancer immunotherapy. Pyroptosis, a lytic programmed cell‐death pathway unlike apoptosis, is considered a type of immunogenic cell death (ICD) that can intensify the ICD process in tumor cells, releasing dramatically increased tumor‐associated antigens and damage‐associated molecular patterns to promote cancer immunotherapy. Herein, a tumor cell membrane‐targeted aggregation‐induced emission photosensitive dimer is found to be able to achieve highly efficient ICD under the synergistic effect of photodynamic and photothermal therapy. The photosensitive dimer can efficiently produce type‐I reactive oxygen species (ROS) by photodynamic therapy in hypoxic tumor tissue, leading to pyroptosis by direct cell membrane damage, which is further reinforced by its photothermal effect. Furthermore, the enhanced ICD effect based on the dimer can completely eliminate the primary tumor on the seventh day of treatment and can also boost systemic antitumor immunity by generating immune memory, which is demonstrated by the superior antitumor therapeutic effects on both solid tumors and metastatic tumors when healing 4T1 tumor mouse models with poor immunogenicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Advanced Materials and School of Chemistry and Chemical Engineering, Southeast University, Nanjing, 211189, China.
- Advanced Materials and Liquid Crystal Institute and Materials Science Graduate Program, Kent State University, Kent, OH, 44242, USA.
ORCID-Profile: Quan Li
Förderung
- Jiangsu Innovation Team Program
- NNSFC
- Priority Academic Program Development of Jiangsu Higher Education Institutions
- Scholars Programs of Southeast University
- National Natural Science Foundation of China
Zitieren
APA
Tang, Y., Bisoyi, H. K., Chen, X. M., Liu, Z., Chen, X., Zhang, S., & Li, Q. (2023). Pyroptosis‐Mediated Synergistic Photodynamic and Photothermal Immunotherapy Enabled by a Tumor‐Membrane‐Targeted Photosensitive Dimer. Advanced Materials, 35(25). https://doi.org/10.1002/adma.202300232
Vancouver
Tang Y, Bisoyi HK, Chen XM, Liu Z, Chen X, Zhang S, et al. Pyroptosis‐Mediated Synergistic Photodynamic and Photothermal Immunotherapy Enabled by a Tumor‐Membrane‐Targeted Photosensitive Dimer. Advanced Materials. 2023;35(25). doi:10.1002/adma.202300232
BibTeX
@article{Tang2023,
author = {Tang, Yuqi and Bisoyi, Hari Krishna and Chen, Xu-Man and Liu, Zhiyang and Chen, Xiao and Zhang, Shu and Li, Quan},
title = {Pyroptosis‐Mediated Synergistic Photodynamic and Photothermal Immunotherapy Enabled by a Tumor‐Membrane‐Targeted Photosensitive Dimer},
journal = {Advanced Materials},
year = {2023},
volume = {35},
number = {25},
doi = {10.1002/adma.202300232}
}
EUVIMED